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Munich, GermanyABSTRACT Genetically encoded calcium indicators have become instrumental in imaging signaling in complex tissues and
neuronal circuits in vivo. Despite their importance, structure-function relationships of these sensors often remain largely unchar-
acterized due to their artificial and multimodular composition. Here, we describe a combination of protein engineering and
kinetic, spectroscopic, and biophysical analysis of the Fo¨rster resonance energy transfer (FRET)-based calcium biosensor
TN-XXL. Using fluorescence spectroscopy of engineered tyrosines, we show that two of the four calcium binding EF-hands
dominate the FRET output of TN-XXL and that local conformational changes of these hands match the kinetics of FRET change.
Using small-angle x-ray scattering and NMR spectroscopy, we show that TN-XXL changes from a flexible elongated to a rigid
globular shape upon binding calcium, thus resulting in FRET signal output. Furthermore, we compare calcium titrations using
fluorescence lifetime spectroscopy with the ratiometric approach and investigate potential non-FRET effects that may affect
the fluorophores. Thus, our data characterize the biophysics of TN-XXL in detail and may form a basis for further rational engi-
neering of FRET-based biosensors.INTRODUCTIONFo¨rster resonance energy transfer (FRET) between fluores-
cent protein variants has become a powerful method to
detect protein interactions and conformational change in
living cells (1–3). Unimolecular FRET is the read-out
mode in a large number of biosensors that employ a donor
and acceptor fluorescent protein, predominantly cyan fluo-
rescent protein (CFP) and yellow fluorescent protein (YFP)
or improved derivatives thereof (4–6). Genetically encoded
calcium indicators (GECIs) enable observation of intracel-
lular signaling in multicellular tissues and neuronal activity
in living organisms (7,8). The currently available GECIs
can be subdivided into single-wavelength indicators like
the GCaMPs (9) and GECOs (10) on the one hand and
dual-wavelength indicators based on FRET on the other
hand. There has been a strong interest in the continuous
improvement of these types of sensors in terms of sensi-
tivity, kinetics, and biocompatibility. The prototypical
FRET-based Cameleons (11,12) and the subsequent deriv-
atives YC3.6 (13) or Cameleon-Nano (14) employ calmod-
ulin (CaM) and a CaM-binding peptide such as M13 from
myosin light-chain kinase as calcium-dependent interaction
domains. Sensors with redesigned interaction interfaces
between CaM and its binding peptide have been generated
(15). To avoid perturbation of CaM-dependent signal
networks inside cells, and to simplify sensor design,
Troponin C (TnC) has been used to replace CaM/M13
within biosensors (16). TnC is a calcium-binding proteinSubmitted January 9, 2012, and accepted for publication March 27, 2012.
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0006-3495/12/05/2401/10 $2.00specialized in regulating muscle contraction, with no other
known signaling function. Ca2þ binding to chicken skeletal
muscle TnC has been extensively studied by exploiting
endogenous aromatic amino acid fluorescence (17–19).
The protein consists of an N-terminal regulatory lobe
with two sites that bind calcium specifically with lower
affinity and a C-terminal structural lobe with another two
sites that bind calcium with high affinity and also bind
magnesium (20). Structural changes in TnC have been
followed by circular dichroism spectroscopy (21), NMR
(22,23), x-ray scattering (24), and crystallography (25).
TnC-based calcium biosensors were subsequently further
engineered to abolish magnesium binding and to enhance
FRET change by incorporation of a circular permutation
of the acceptor fluorescent protein Citrine (26). The latest
signal-optimized variant, TN-XXL, arose from domain
rearrangement, by which two copies of the C-terminal
lobe of chicken skeletal TnC were linked to each other
and sandwiched between CFP and cpCitrine (27). This pro-
cedure abolished the N-terminal lobe of TnC completely
and served as a first step away from the use of naturally
occurring calcium-binding proteins to a more synthetic,
biocompatible sensor architecture. As a better under-
standing of sensor biophysics may serve as a basis for
further rational improvements of sensor design and perfor-
mance, we here set out to characterize TN-XXL function in
more detail. Our results depict the biophysical parameters
of TN-XXL function, give insight into how the initial
calcium binding to TN-XXL results in FRET output, and
pinpoint optimization potential for further rational sensor
engineering.doi: 10.1016/j.bpj.2012.03.065
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Gene construction
TN-XXL and its ‘‘Amber’’ variants were cloned into pRSETB vector (Invi-
trogen, Carlsbad, CA) using flanking BamHI/EcoRI restriction sites. As
constructs for tyrosine fluorescence experiments, only the TN-XXL
calcium-binding domain, without the FPs, was cloned into pRSETB,
changing the flanking restriction sites from SphI/SacI to BamHI/EcoRI.
Mutant constructs of the indicator variants were generated by site-directed
mutagenesis using the primer extension method (Stratagene, La Jolla, CA).
For protein expression, indicator constructs were subcloned into a modified
version of the pET16b vector (EMD Biosciences, San Diego, CA) contain-
ing an N-terminal tobacco etch virus (TEV) protease cleavage site.Protein expression and purification
Indicator variants were expressed in E. coli BL21 and treated as described
previously (16). Clear lysates were purified via HisTrap Ni-NTA columns
(GE Healthcare, Waukesha, WI) according to the manufacturer’s protocol.
The eluate was incubated with TEV protease in the presence of 5 mM
dithiothreitol (DTT) at 4C overnight for His-tag removal. The cleaved
protein was obtained in the flow-through during Ni-NTA affinity chroma-
tography. Protein variants were further purified by size-exclusion chroma-
tography on a Superdex 200 column (16/60, GE Healthcare) equilibrated
with the respective measurement buffers. Fractions containing protein
were pooled and concentrated using a 10 kD Centricon ultrafiltration device
(Millipore, Billerica, MA). Analytical size-exclusion chromatography was
performed using a Superose 12 column (10/300, GE Healthcare) equili-
brated with buffer A (30 mM MOPS, 100 mM KCl, 100 mM EDTA,
100 mM EGTA, pH 7.5) with EGTA (2 mM, Ca2þ-free) or CaCl2
(10 mM, high Ca2þ). Before chromatographic separation, the samples
were pretreated with 2 mM EGTA and 10 mM CaCl2, respectively.
For NMR experiments, expression of the uniformly 15N- and 13C-labeled
histidine-tagged single-lobe domain of TN-XXL (comprising EF-hands
3 and 4) was performed at 37C in minimal medium with 15N-ammonium
chloride and 13C6-D-glucose as the sole nitrogen and carbon sources. The
fusion protein was purified by immobilized metal affinity chromatography
on Ni-NTA agarose (Qiagen, Venlo, The Netherlands) and subsequently
cleaved with TEV protease. The released EF34 TN-XXL was further puri-
fied by reverse-phase HPLC.Analytical ultracentrifugation
The sedimentation velocity experiments were performed using an Optima
XL-I analytical ultracentrifuge (Beckman Coulter, Brea, CA) equipped
with an An-60 Ti rotor and double-sector centerpieces at 20C. The sample
proteins were used at a concentration of 18–23 mM in buffer A (30 mM
MOPS, 100 mM KCl, 100 mM EDTA, 100 mM EGTA, pH 7.5) with
EGTA (2 mM, Ca2þ free) or CaCl2 (10 mM, high Ca
2þ) added. Buffer
density and viscosity were measured using a DMA 5000 densitometer
and an AMVn viscosimeter, respectively (both from Anton Paar, Graz,
Austria). Concentration profiles were measured at 280 nm at a speed of
50,000 rpm, followed by evaluation using the SEDFIT software (version
11.71 (28)) to obtain the diffusion-corrected sedimentation coefficient
distributions (c(s)-distributions).Fluorescence spectroscopy
Ca2þ affinity of TN-XXL and variants were measured by steady-state fluo-
rescence spectroscopy using a Cary Eclipse fluorometer (Varian, Palo Alto,
CA) with temperature-controlled cuvette holder. Dissociation kinetics were
measured with a stopped-flow RX2000 rapid kinetics accessory unit
(Applied Photophysics, Leatherhead, UK) with a dead time of ~8 ms,Biophysical Journal 102(10) 2401–2410with excitation at 432 nm and detection at 475 nm and 527 nm. Free
Ca2þ concentrations were calculated using the Maxchelator (http://
maxchelator.stanford.edu). Ca2þ titrations were carried out in calcium titra-
tion buffer RT (30 mM MOPS, 100 mM KCl, 1 mM MgCl2, 10 mM
K2EGTA, and 0–10 mM CaCl2, pH 7.2) according to the methods of Tsien
and Pozzan (29) at a protein concentration of 0.5 mM. Stopped-flow
measurements of these variants were conducted at a protein concentration
of 0.5 mM with 2 mM Ca2þ in buffer SF (10 mM MOPS, 50 mM KCl,
1 mM MgCl2, and 1 mM DTT, pH 7.5) being rapidly mixed with an equal
volume of EGTA (10 mM) in buffer SF (30).
Ca2þ titrations monitoring tyrosine fluorescencewere carried out with the
same stopped-flowunit as described above in a 2-mLvolume of 1mMprotein
in buffer YT (200 mM MOPS to prevent pH changes upon Ca2þ addition,
100 mMKCl, 2 mM EGTA, 1 mMMgCl2, and 1 mMDTT, pH 7.2). Micro-
liter amounts of CaCl2 solution (250 mM) were added at 30
C with tyrosine
fluorescence excited at 275 nm and monitored at 303 nm using the Cary
Eclipse fluorometer. The rate of conformational change of the binding
domainalonewas followedby stopped-flow tyrosinefluorescenceat a protein
concentration of 5 mM in buffer SF, as described above.
The time-resolved detection of the fluorescence decay of TN-XXL was
performed with a Fluotime100 fluorescence spectrophotometer (Picoquant,
Berlin, Germany) based on a picoHarp300 unit and using a pulsed diode
laser (LDH-440 and LDH-P-C-470; center wavelength, 440 nm and
470 nm; pulse width, 54 ps and 88 ps; repetition frequency, variable, here
10MHz) as an excitation source. Fluorescence decay curves were measured
by time-correlated single-photon counting with a resolution of R300 ps
(31,32). Decay curves were analyzed by iterative reconvolution of the
instrument response function, IRF(t), with an exponential model function,
M(t), using the FluoFit software (version 4.4; Picoquant) using:
IðtÞ ¼ IRFðtÞ  MðtÞ (1)
X h  ti
MðtÞ ¼
i¼ 13
ai  exp 
t
; (2)
where ti are the characteristic lifetimes and ai are the respective intensities.
The average lifetime, t , was calculated asave
tave ¼
P
i¼ 13
½ai  ti
P
i¼ 13
½ai (3)
Small-angle x-ray scattering
Small-angle x-ray scattering (SAXS) data collection was performed at
ID14-3 European Molecular Biology Laboratory (EMBL)/European
Synchrotron Radiation Facility (Grenoble, France) and X33 EMBL/
Deutsches Elektronen-Synchrotron (Hamburg, Germany) beamlines.
TN-XXL samples were purified by size-exclusion chromatography in
buffer A (30 mM MOPS, 100 mM KCl, 100 mM EDTA, and 100 mM
EGTA, pH 7.5) containing EGTA (2 mM, Ca2þ free) or 10 mM CaCl2
(10 mM high Ca2þ). Protein samples and buffer controls were centrifuged
for 10 min at 13,200 g before data acquisition. Samples were measured in
concentrations of 1, 2, 5, and 10 mg/mL. The running buffer of the size-
exclusion chromatography (buffer A) was used for buffer correction. No
particle interaction or aggregation was observed in the tested concentration
range. All samples were checked for radiation damage by comparison of the
successive 10-s frames of sample exposure. Raw data were analyzed and
processed using the ATSAS package (version 2.4 (33)) according to the
literature (34). Sets of independent ab initio models were calculated using
GASBOR (35). DAMAVER (36) was used for alignment and averaging.
Figures and modeling were carried out using SITUS (37) and UCSF
Chimera (38).
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NMR experiments were carried out at 303 K on Bruker DRX spectrometers
equipped with z-gradient cryoprobes operating at different fields (600–
800 MHz). NMR samples were prepared at a final protein concentration of
1 mM in 20 mM Bis-Tris (pH 7.0), 100 mM KCl, 10 mM DTT, and 10%
2H2O. The metal-free and calcium-loaded samples contained 20 mM
EDTA/20 mM EGTA and 10 mM CaCl2, respectively. To obtain sequence-
specific backbone resonance assignments, a standard set of triple-resonance
NMR experiments was performed. The spectra were processed using
NMRpipe (39) and analyzed using SPARKY (40) and CARA (41).FIGURE 1 Fluorescence spectroscopy of single tyrosine substitutions in
the calcium binding domain of TN-XXL. (A) Schematic representation of
the four calcium binding EF-hands of the TN-XXL calcium binding
domain. Endogenous phenylalanine residues were mutated to tyrosines to
report local calcium binding at individual EF-hands. (B) Calcium titrations
of single tyrosine substitutions in comparison to TN-XXL FRET. Standard
error of the mean depicted as error bars and fluorescence normalized. (C)
Calcium-dissociation kinetics of EF3-1 and EF3-2. Tyrosine measurements
used excitation at 275 nm with emission recorded at 303 nm. TN-XXL
FRET control was performed with excitation at 432 nm and cpCitrine
(YFP) emission was recorded at 527 nm. All data are averages of three inde-
pendent experiments.RESULTS
Correlating calcium binding and FRET output
We first investigated calcium binding to individual EF-
hands of the TN-XXL calcium-binding domain via tyrosine
fluorescence. The binding domain of TN-XXL comprises
two concatenated C-terminal lobes (EF-hands 3 and 4
with residues 94–162) from chicken skeletal muscle TnC,
thus consisting of two identical pairs of EF-hands connected
by a short linker peptide (Fig. 1 A). To monitor calcium
binding to the individual EF-hands of TN-XXL directly,
we mutated endogenous phenylalanine residues in the
chelating loop of each EF-hand to tyrosines. Tyrosine resi-
dues present at the corresponding positions in the related
wild-type human cardiac TnC are known to report Ca2þ
binding to one specific EF-hand with an increase of intrinsic
fluorescence (30). We generated a series of constructs in
which one of the four Phe residues was selectively
exchanged (EF3-1, EF4-1, EF3-2, EF4-2), with one control
that contained tyrosines in all four binding sites (TN-XXL
4Tyr). TN-XXL 4Tyr showed a calcium affinity and
off rate that was indistinguishable from that of TN-XXL
when monitored via FRET (Fig. S1, A and B, in the Support-
ing Material). Direct calcium binding to the individual
EF-hands of TN-XXL was monitored at 23C and pH 7.2.
For this purpose, we used the TN-XXL calcium-binding
domain without the flanking fluorescent proteins due to
the presence of one endogenous tryptophan and 8–10 tyro-
sines within each fluorescent protein. These four constructs,
containing only a single tyrosine residue per construct, were
analyzed by steady-state (Fig. 1 B) and stopped-flow fluo-
rescence spectroscopy (Fig. 1 C). Calcium-induced tyrosine
fluorescence increases were significantly different in both
EF-hand types and varied between ~75% (EF3-1 or 3-2)
and only ~6% (EF4-1 and 4-2) (Fig. S1, C and D). For
EF3-1 and EF3-2, Kd values of 690 nM and 820 nM, respec-
tively, were determined, matching the measured Kd of
TN-XXL, which was 830 nM as monitored by FRET. In
contrast, EF4-1 and EF4-2 showed Kd values of 180 nM
and 2.05 mM, respectively. Thus, EF3-1 and EF3-2 show
a calcium affinity that is in good agreement with the value
of TN-XXL and therefore were identified as the major deter-
minants of the sensor’s FRET signal. Notably, EF3-1 shows
a broader binding curve in comparison to EF3-2, whichsuggests structural instability of the first EF-hand due to
the lack of an N-terminal fusion partner. The assumption
of a less ordered structure is further supported by the
NMR results (see Fig. 3 C) Ca2þ dissociation kinetics
were determined for EF3-1 and EF3-2 (Fig. 1 C). Due to
their low signal strength and the missing relation to
TN-XXL affinity, EF4-1 and EF4-2 were not included in
this experiment. The resulting Ca2þ-dissociation time
constants, tdecay, were calculated using monoexponential
fits and compared with the FRET fluorescence decay of
TN-XXL. For FRET, a tdecay of 311 ms was measured,
whereas EF3-1 and EF3-2 show tdecay values of 317 ms
and 277 ms, respectively. Thus, unbinding of bound Ca2þBiophysical Journal 102(10) 2401–2410
2404 Geiger et al.locally detected at EF-hands 3-1 and 3-2 displayed off-
kinetics similar to the global changes reported by FRET.Hydrodynamics of TN-XXL
Hydrodynamic analysis of TN-XXL was performed using
a multimethod approach to investigate the conformational
switch upon Ca2þ binding underlying the FRET changes.
Under both conditions—high calcium (10 mM CaCl2) orFIGURE 2 Hydrodynamics of TN-XXL. (A) Coomassie staining of SDS- and
of TN-XXL in Ca2þ-free and high-Ca2þ conditions on a Superose 12 column (1
tation-velocity experiments in the analytical ultracentrifuge with TN-XXL con
Ca2þ. (D) Solution scattering data for TN-XXL in Ca2þ-free and high-Ca2þ c
respectively, of TN-XXL in Ca2þ-free and high-Ca2þ conditions. (G) Final ave
runs of TN-XXL in Ca2þ-free (upper) and high-Ca2þ (lower) states. (H) Shape o
of crystal structures of ECFP and citrine (PDB 1CV7 and 1HUY). All experime
added for Ca2þ-free or high-Ca2þ conditions, respectively.
Biophysical Journal 102(10) 2401–2410calcium-free (2 mM EGTA)—recombinant purified
TN-XXL remained strictly monomeric (Fig. 2, A–C).
Analytical size-exclusion chromatography of TN-XXL
showed a large shift of the elution volume, Ve, indicating
a significant change of the hydrodynamic volume with its
monomeric status maintained. Further analysis by analytical
ultracentrifugation confirmed these results shown as
sedimentation-coefficient distributions (Fig. 2 C, c(S)).
In sedimentation velocity experiments, the sedimentationnative PAGE gels of purified TN-XXL. (B) Size-exclusion chromatography
0/300). (C) c(S) distribution calculated using SEDFIT (28) from sedimen-
centrations of 18 and 23 mM in the presence and absence, respectively, of
onditions. (E and F) Distance distribution functions P(r) and Kratky plot,
raged DAMAVER (36) ab initio shapes from independent GASBOR (35)
f TN-XXL in Ca2þ-free state manually docked with cartoon representations
nts were carried out in buffer A. Either 2 mM EGTA or 10 mM CaCl2 were
Modular Analysis of the Biosensor TN-XXL 2405constant S20,W shifted from 5.05 at high calcium to 4.32 at
calcium-free conditions. As a measure for the change in
maximal shape asymmetry, calculation of the frictional ratio
f/f0 showed values of 1.2 in the calcium-saturated state,
correlating with a rather compact structure, as usually
observed for globular proteins, and a frictional ratio f/f0 of
1.5 in the calcium-depleted state, indicating an elongated
shape (42). Molecular masses of TN-XXL in the calcium
unbound and bound states determined from broadening of
the sedimenting boundary in sedimentation-velocity exper-
iments were 74.1 kDa and 67.8 kDa mol wt, respectively,
and are in good agreement with the theoretical molecular
mass of a monomer (74.1 kDa). Finally, SAXS allowed us
to associate these results with molecular geometry parame-
ters like radius of gyration, Rg, and maximum diameter,
Dmax, of the proteins and with approximations of folding
status and conformation. The obvious differences in
TN-XXL shapes in the presence and absence of Ca2þ can
already be seen in the scattering curves (Fig. 2 D), and
they are even more pronounced in the interatomic distance
distribution function, P(r) (Fig. 2 E). A radius of gyration,
Rg, of 3.85 nm suggests an elongated calcium-free con-
formation, in comparison to an Rg of 3.32 nm for the
calcium-saturated state, confirming its more compact struc-
ture. Calcium-bound and calcium-free states are clearly
folded, as can be judged from the bell-shaped curves (43)
in the Kratky plots (Fig. 2 F). Maximum particle size,
Dmax, values of 14 nm (Ca
2þ-free) versus 11 nm (Ca2þ-
bound) fit well to possible arrangements of the enhanced
CFP (ECFP)/cpCitrine pair, allowing the assumption of a
strong distance contribution to the FRET change of
TN-XXL. To visualize the results, low-resolution shapes
were calculated ab initio from the scattering data (Fig. 2 G).
The location of the two b-barrel domains is evident in the
outstretched Ca2þ-free form but ambiguous in the compact
Ca2þ-bound form. To better illustrate the possible posi-
tioning of the two FPs, the available structures for ECFP
and citrine (PDB 1CV7 and 1HUY) were manually docked
in the shape envelope of the Ca2þ-free form (Fig. 2 H).NMR characterization of a single C-lobe domain of
TN-XXL
To further investigate the different rigidities under both condi-
tions, we undertook a solution NMR characterization of
a single C-terminal lobe of TnC containing one pair of
EF-hands from TN-XXL (EF34). The 1H-15N heteronuclear
single-quantum coherence (HSQC) spectrum of the cal-
cium-loaded form (Fig. 3 A) shows that EF34—considering
the good dispersion of signals in both proton and nitrogen
dimensions—adopts a folded conformation. Moreover, we
obtained the complete assignment of HN and Ca chemical
shifts of EF34. On the basis of chemical shift index values
(44), we derived a secondary structure prediction, shown in
Fig. 3 C, which is essentially identical to that obtained forthe wild-type C-terminal domain of chicken skeletal TnC
and consistent with its high-resolution structure, PDB ID
code 1TNW19. This finding suggests that the three TN-XXL
mutationsN108D,D110N, and I130Tdonot affect the tertiary
fold of EF34. This result gains further support from the char-
acteristic amide proton chemical shifts of residues Gly111 and
Gly147. As in wild-type TnC, these residues show remarkable
downfield chemical shifts in EF34, suggesting that they are
similarly involved in a hydrogen bond that stabilizes
calcium-binding sites. Finally, to address the role of metal in
the domain organization, we also investigated the apo form
of EF34. As displayed in Fig. 3 B, there is considerably less
signal dispersion in the 1H-15N HSQC spectrum of the apo
form than in the calcium-loaded form. SecondaryCa chemical
shifts are also less pronounced in the metal-free form (Fig. 3
C), even though they still deviate significantly from zero.
Taken together, these data indicate that in the absence of
calcium, the tertiary structure of protein is partially lost and
the secondary structural elements are less stable than in the
metal-loaded protein. Notably, the secondary structure, in
particular the firsta-helix, of theEF-handmotif (EF3) appears
to bemore affected than EF4. However, thismight also be due
to the lack of a stabilizing N-terminal fusion partner.Truncations and ‘‘Amber’’ substitutions in TN-XXL
Strong conformational changes such as those demonstrated
here might affect fluorescence properties of fused fluores-
cent proteins by direct conformational coupling onto the
b-barrels. To address this issue, which potentially impairs
the signal output, we generated a series of four fusion con-
structs containing only one fluorescent protein (Fig. S2 A).
Two constructs contained the calcium-binding domain of
TN-XXL fused to one of the fluorescent proteins and lack-
ing the second (TN-XXL DcpCit and TN-XXL DECFP). In
two other constructs, one of the FPs was replaced with a
defective FP in which an ‘‘Amber’’-like 67Cys mutation
(45) prevented fluorophore formation yet retained the fully
folded b-barrel structure (TN-XXL cpCit and TN-XXL
ECFP). These constructs acted as reporters for fluorescence
changes caused by non-FRET mechanisms. We tested the
calcium sensitivity of all constructs with steady-state
(Fig. S2, B–G) and time-resolved fluorescence spectroscopy
(Table S1). The fluorescence emission of ECFP, either
alone or in fusion constructs, was minimally reduced by
the addition of calcium (z2%, Fig. S2, B–D). cpCitrine
and all its control constructs maintained stable fluorescence
properties at all calcium concentrations (Fig. S2, E–G).
Thus, the Ca2þ-dependent conformational change does not
affect the fluorescence properties of the single FPs.Fluorescence-lifetimecalciumtitrationsofTN-XXL
To correlate the time-resolved fluorescence signal of TN-
XXL with the sensor properties obtained for steady-stateBiophysical Journal 102(10) 2401–2410
FIGURE 3 NMR characterization of the
calcium-binding domain of TN-XXL. (A and B)
1H-15N HSQC spectra of 15N13C-labeled single-
lobe EF34 TN-XXL domain (residues 94–162).
Data acquisition was performed at 303 K on an
800 MHz spectrometer with the Ca2þ-loaded (A)
and Ca2þ-free form (B). (C) Upper, Secondary-
structure elements (a-helices and b-strands) in
dependence of the sequence in EF34 TN-XXL in
the Ca2þ-loaded form as derived by the chemical
shift index based on Ca resonance assignments.
Lower, Secondary chemical shift analysis for
EF34 of TN-XXL in the Ca2þ-loaded (black) and
Ca2þ-free forms (gray).
2406 Geiger et al.FRET spectroscopy, we performed Ca2þ titrations with both
methods in parallel and followed the donor fluorescence
decay. Due to initial FRET, the overall donor fluorescence
lifetime in TN-XXL in zero calcium was already shorter
than that of the control construct TN-XXL cpCit, contain-
ing only ECFP (Fig. 4 A, curves 1 and 2, respectively)).
Upon saturation with Ca2þ, a further shortening of the fluo-
rescence lifetime could be observed (curve 3). For ECFP
fluorescence decay, both biexponential fits (46–48) and
triexponential fits (49,50) have been reported in vitro and
in living cells. In our experiments, the triexponential fit
notably improved the quality for the fit of ECFP decay
(Fig. 4 A and c2 values in Table S2). A factorial analysis
of the triexponential fit of the Ca2þ titration yielded a
surprising distribution of lifetimes and amplitudes (Fig. 4 B
and Table S2). Only the shortest of all three lifetimes
showed a significant Ca2þ dependency, decreasing by
>25% from 0.696 to 0.503 ns. The longer lifetimes, t2
and t3, remained unaffected. The relative amplitude a1 of
the fast lifetime increased by 28% to 64% at calcium satu-
ration, whereas the amplitudes of the longer, invariant life-
times dropped by 6% for t2 and 22% for t3. It cannot be
excluded that the decay represented by these lifetimes has
contributions of both the shorter lifetimes of non-FRETBiophysical Journal 102(10) 2401–2410donor molecules and less efficient FRET processes com-
pared to those described by t1. However, the longest
lifetime, t3, at high calcium (12%)—nearly identical in
TN-XXL and TN-XXL cpCit—is doubtless associated
with donor molecules that do not undergo FRET. The value
of high-calcium a3 is in very good agreement with the frac-
tion of the cpCitrine chromophore that is protonated at
pH 7.2 (~15%; Fig. S3). Thus, in contrast to earlier studies
of other FRET-based GECIs, no fraction of nonfunctional
biosensors has to be postulated. Instead, at low calcium,
TN-XXL molecules exhibit only low FRET efficiency,
whereas at high calcium, all ECFPs undergo FRET except
for those that are bound to an acceptor with a protonated
chromophore. A second possible explanation for a non-
interacting fraction of FRET-based indicators could be the
photoconversion of the acceptor upon long and intense illu-
mination (51,52). Under our experimental conditions, we
found no indication for a substantial contribution thereof,
but under fluorescence lifetime imaging (FLIM) conditions
with more continuous illumination, this effect might hamper
the Dtave signal further. The boundary cases for TN-XXL
were obtained at calcium concentrations of 0 and 40 mM
and yielded average fluorescence lifetimes of 2.11 and
1.26 ns and therefore an average fluorescence lifetime
FIGURE 4 Fluorescence lifetime spectroscopy of TN-XXL. (A) Upper,
Experimental and fitted fluorescence donor decay curves of TN-XXL cpCit
control (curve 1), TN-XXL in the Ca2þ-free state (curve 2), TN-XXL in the
high-Ca2þ state (curve 3), and the instrument response function (curve 4) (exci-
tation of ECFP at 440 nm and donor emission recorded at 475 nm). Experi-
mental data are fitted with multiexponential functions with amplitude ai and
lifetimes ti.Lower,Weighted residuals of bi-and triexponential fits.All resulting
parameters are listed in Table S2. (B) Ca2þ dependence of relative amplitudes
from the triexponential fit (upper) and normalized fluorescence lifetimes
(lower). (C) Ca2þ dependence of the normalized average fluorescence lifetime
tave (black). Ratiometric steady-state titration of TN-XXLwithECFPand cpCi-
trine fluorescencemeasuredwith excitation at 432 nm and emission recorded at
475/527 nm (gray). The dotted line represents the half-maximal signal change.
Modular Analysis of the Biosensor TN-XXL 2407change, Dtave, of 0.85 ns without prior subtraction of sub-
populations. The Ca2þ titration of Dtave showed a sigmoidal
curve corresponding to the titration curve obtained by ratio-
metric spectroscopy (Fig. 4 C). The apparent Kd obtained
with the lifetime analysis was 453 nM, in contrast to the
Kd of 830 nM determined by intensity-based measurements.Effects of pH and temperature on TN-XXL
To estimate the sensor performance under different environ-
mental conditions, we tested pH and temperature effects on
affinity and kinetics of TN-XXL (Fig. 5 and Table S3).
Three temperatures were tested with a constant pH of 7.2.
Although the affinity decreased slightly (Kd rising slightly
from 830 to 1210 nM, Fig. 5 A), the off-kinetics, represented
by the monoexponentially fitted Ca2þ dissociation time
constant, tdecay, decreased drastically from 620 ms at 23
C
to only 129 ms at 37C (Fig. 5 C). pH values tested at a
constant temperature of 23C ranged from pH 6.5 to 8.0.
TN-XXL affinity increased with pH, dropping from
1030 nM at pH 6.5 to 451 nM at pH 8.0 (Fig. 5 B). The
Ca2þ dissociation time constant, tdecay, hereby changed
from 620 ms to 425 ms with increasing pH (Fig. 5 D).DISCUSSION
Here, we present a biophysical analysis of the FRET-based
calcium biosensor TN-XXL (27) using a variety of
approaches. The aim of these efforts was to increase our
understanding of the modular build-up of a FRET-based
calcium sensor to identify optimization potential for rational
engineering.
We monitored calcium binding to individual EF-hands of
the calcium-binding moiety of TN-XXL by engineering a
number of mutants with tyrosine substitutions. This allowed
us to determine the affinity and kinetics for binding events in
each EF-hand separately. We could divide the four EF-hands
of the binding domain of TN-XXL into two distinct classes:
EF-hands 3-1 and 3-2 dominate the FREToutput of the indi-
cator, whereas calcium binding to EF-hands 4-1 and 4-2
does not contribute detectably to the FRET signal and
may have more of a stabilizing function. One avenue of
further improvement would be to eliminate completely
calcium binding to EF-hands 4-1 and 4-2, thus reducing
the buffer capacity of the sensor. As EF-hands typically
function in high-affinity binding as pairs that stabilize
each other (24), it will be important to maintain the support-
ing scaffolding function the hands exert on EF-hands 3-1
and 3-2, similar to mutational inactivation of the first of
the EF-hands in the N-terminal lobe of human cardiac
TnC (53). Our tyrosine fluorescence data show that fusion
of fluorescent proteins to the binding domain does not
affect sensor kinetics at a detectable level. The matching
dissociation time constants suggest a model with concerted
slow conformational change of the entire binding domainBiophysical Journal 102(10) 2401–2410
FIGURE 5 Temperature and pH dependency.
(A and B) Ca2þ titration curve of TN-XXL at
different temperatures (A) and pH values (B).
(C and D) Ca2þ-dissociation kinetics of TN-XXL
at different temperatures (C) and pH values (D)
(excitation at 432 nm and emission recorded at
475/527 nm). All data are normalized averages of
three independent experiments in buffer A. All
resulting values are summarized in Table S3.
2408 Geiger et al.triggered by initial Ca2þ dissociation rather than with
sequential transduction of the conformational change.
We also showed that the large FRET change in TN-XXL
after calcium binding is associated with a distinct conforma-
tional change of the protein and cannot be related to orien-
tational changes between the fluorophores alone. Analytical
ultracentrifugation, size-exclusion chromatography, and
SAXS consistently reported an outstretched calcium-free
conformation and a large structural change upon calcium
binding to a more compact, globular calcium-saturated
conformation. The fluorescent donor and acceptor proteins,
presumably localized at opposite ends of the elongated
structure at zero calcium, thereby move several nanometers
closer to each other and associate in close proximity. We
complemented our results from SAXS analysis with NMR
data on the single C-terminal lobe domain in TN-XXL, indi-
cating that the binding domain adopts a compact folded
conformation in the calcium-bound form that is partially
lost in the absence of calcium. We conclude that the engi-
neering potential to further improve the indicator’s signal
strength is twofold. The FRET efficiency in the flexible
calcium-free form is more affected by the distance between
the two FPs than by a specific orientation. Hence, reducing
FRET in the unbound state can most likely be achieved
by prolonging the linker sequence. Enhancing the FRET
efficiency of the already compact calcium-bound state,
however, requires the improvement of the alignment of the
two FP b-barrels toward an optimal k2 value according to
the Fo¨rster equation. In this case, the binding domain’s rigid
conformation supports the concept of a confined and opti-
mized orientation. For both strategies, the vast combinato-
rial possibilities of the required modifications in the aminoBiophysical Journal 102(10) 2401–2410acid sequence will necessitate high-throughput screening
to ensure maximum signal optimization.
The conformational change in TN-XXL does not induce
structural distortions of the fluorophores. Using defective
donor or acceptor proteins that incorporate the Amber
mutation (45), we could observe no additional Ca2þ-depen-
dent effect on the fluorescence of ECFP and cpCitrine
(Fig. S2). Steady-state fluorescence spectroscopy revealed
a strong temperature dependence of the off-kinetics, as
well as a pH dependence of off-kinetics and affinity (Fig. 5).
Furthermore, the change of the average fluorescence life-
time, Dtave, of 0.85 ns (YC3.6 shows only 0.46 ns (48))
together with an apparent Kd of 453 nM (Fig. 4 C) make
TN-XXL a good starting point to generate GECIs tailor-
made for FLIM applications. The apparently higher calcium
affinity determined for TN-XXL by titration of the donor
fluorescence lifetime compared to that of the fluorescence
intensity ratio of acceptor and donor can be explained
by the existence of fast FRET processes with rates of
1/300 ps or larger. Indeed, processes in this order of magni-
tude are faster than the instrument response function of the
setup; they therefore cannot be resolved and detected and
will be missed in the donor fluorescence lifetime titration.
Such efficient FRET processes would shift the apparent
fluorescence lifetime change toward lower calcium concen-
trations and can explain the discrepancy in the Kd values
determined by lifetime and ratio. In fact, this difference
points toward an experimental problem in microscopic
FLIM-FRET studies in cells and tissue. The time resolution
practically achievable in measurements in cells and tissue in
such studies is even lower (500 ps or longer) compared to
measurements of purified GECIs in aqueous solution due
Modular Analysis of the Biosensor TN-XXL 2409to experimental limitations, e.g., lower count numbers or
larger scattering amplitudes. As a consequence, fluores-
cence lifetime calibration of FRET-based biosensors should
always be carried out in the same microscope setup and
using the same conditions under which the measurements
in cells will be performed. Despite the progress in GECI
development and their exciting in vivo use in modern fluo-
rescence microscopy studies (8), high impact FLIM applica-
tions do not exist yet. This can be mainly attributed
corruption of the Dtave due to the low dynamic range of
the lifetime change (here 40%, often only 10–20% at
most) and the frequently observed complexity of the multi-
exponential donor fluorescence decay and noninteracting
fraction in FRET constructs. Next-generation GECIs might
employ improved CFPs such as the latest Cerulean (54) or
mTurqouise variants (55), with higher fluorescence quantum
yields and monoexponential fluorescence decays.
In conclusion, this study characterizes the genetically en-
coded calcium indicator TN-XXL in detail and identifies
several options that might be bases for further engineering
of sensors with improved signal strength, faster kinetics,
and reduced buffering potential.SUPPORTING MATERIAL
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